Home > Research > Researchers > Professor David Allsop > Publications

Professor David Allsop

Professor

  1. 2020
  2. Published

    Apathy as a behavioural marker of cognitive impairment in Parkinson's disease: a longitudinal analysis

    Martin, G. P., McDonald, K. R., Allsop, D., Diggle, P. J. & Leroi, I., 1/01/2020, In : Journal of Neurology. 267, 1, p. 214-227 14 p.

    Research output: Contribution to journalJournal article

  3. 2019
  4. Published

    Combined use of CSF NfL and CSF TDP-43 improves diagnostic performance in ALS: A comprehensive analysis on diagnostic and prognostic significance of plasma and CSF NfL, TDP-43, and tau

    Kasai, T., Kojima, Y., Ohmichi, T., Tatebe, H., Tsuji, Y., Noto, Y., Kitani-Morii, F., Shinomoto, M., Allsop, D., Mizuno, T. & Tokuda, T., 1/12/2019, In : Annals of Clinical and Translational Neurology. 6, 12, p. 2489-2502 14 p.

    Research output: Contribution to journalJournal article

  5. Published

    Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients

    Shinomoto, M., Kasai, T., Tatebe, H., Kondo, M., Ohmichi, T., Morimoto, M., Chiyonobu, T., Terada, N., Allsop, D., Yokota, I., Mizuno, T. & Tokuda, T., 5/04/2019, In : PLoS ONE. 14, 4, 13 p., e0211575.

    Research output: Contribution to journalJournal article

  6. 2018
  7. Published

    Blood-based near-infrared spectroscopy for the rapid low-cost detection of Alzheimer’s disease

    Paraskevaidi, M., Morais, C., Freitas, D., Lima, K., Mann, D., Allsop, D., Martin-Hirsch, P. & Martin, F. L., 21/12/2018, In : Analyst. 143, 24, p. 5959-5964 6 p.

    Research output: Contribution to journalJournal article

  8. Published

    Liposome delivery systems for the treatment of Alzheimer’s disease

    Ross, C., Taylor, M. N., Fullwood, N. J. & Allsop, D., 12/12/2018, In : International Journal of Nanomedicine. 2018, 13, p. 8507-8522 16 p.

    Research output: Contribution to journalJournal article

  9. Published

    Raman spectroscopy to diagnose Alzheimer's disease and dementia with Lewy bodies in blood

    Paraskevaidi, M., Morais, C., Halliwell, D., Mann, D., Allsop, D., Martin-Hirsch, P. & Martin, F. L., 2018, In : ACS Chemical Neuroscience. 9, 11, p. 2786–2794 9 p.

    Research output: Contribution to journalJournal article

  10. Published

    Untangled - peptide-based inhibitors of tau aggregation as a potential treatment for Alzheimer's disease

    Allsop, D., Aggidis, A., Fullwood, N. J., Taylor, M. N., Foulds, P., Vincent, S. & Dale, M., 2018, In : Journal of Prevention of Alzheimer's Disease. 5, Suppl 1, p. S15-S16 2 p.

    Research output: Contribution to journalMeeting abstract

  11. 2017
  12. Published

    Development of proteolytically stable N-methylated peptide inhibitors of aggregation of the amylin peptide implicated in type 2 diabetes

    Obasse, I. C., Taylor, M. N., Fullwood, N. J. & Allsop, D., 6/12/2017, In : Interface Focus. 7, 6, 11 p., 20160127.

    Research output: Contribution to journalJournal article

  13. Published

    Increased levels of plasma total tau in adult Down syndrome

    Kasai, T., Tatebe, H., Kondo, M., Ishii, R., Ohmichi, T., Yeung, W. T. E., Morimoto, M., Chiyonobu, T., Terada, N., Allsop, D., Nakagawa, M., Mizuno, T. & Tokuda, T., 30/11/2017, In : PLoS ONE. 12, 11, 12 p., e0188802.

    Research output: Contribution to journalJournal article

  14. Published

    A novel approach to the therapy of Alzheimer's disease based on peptide nanoliposome inhibitors of Aβ and tau aggregation

    Allsop, D., Taylor, M. N., Fullwood, N. J., Michael, M., Aggidis, A., Vincent, S. & Dale, M., 1/11/2017, In : Journal of Prevention of Alzheimer's Disease. 4, 4, p. 385-386 2 p.

    Research output: Contribution to journalMeeting abstract

  15. Published

    α-Synuclein interacts with lipoproteins in plasma

    Nouri Emamzadeh, F. & Allsop, D., 10/2017, In : Journal of Molecular Neuroscience . 63, 2, p. 165-172 8 p.

    Research output: Contribution to journalJournal article

  16. Published

    Differential diagnosis of Alzheimer’s disease using spectrochemical analysis of blood

    Paraskevaidi, M., Morais, C., Lima, K., Snowden, J., Saxon, J., Richardson, A., Jones, M., Mann, D., Allsop, D., Martin-Hirsch, P. & Martin, F., 19/09/2017, In : Proceedings of the National Academy of Sciences of the United States of America. 114, 38, p. E7929–E7938 10 p.

    Research output: Contribution to journalJournal article

  17. Published

    Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and Down syndrome

    Tatebe, H., Kasai, T., Ohmichi, T., Kishi, Y., Kakeya, T., Waragai, M., Kondo, M., Allsop, D. & Tokuda, T., 4/09/2017, In : Molecular Neurodegeneration. 12, 63, 11 p., 63.

    Research output: Contribution to journalJournal article

  18. Published

    Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease

    Kasai, T., Kondo, M., Ishii, R., Tanaka, A., Ataka, S., Shimada, H., Tomiyama, T., Mori, H., Taylor, M. N., Allsop, D., Nakagawa, M., Mizuno, T. & Tokuda, T., 10/04/2017, In : PLoS ONE. 12, 4

    Research output: Contribution to journalJournal article

  19. Published

    Self-Assembly and Anti-Amyloid Cytotoxicity Activity of Amyloid beta Peptide Derivatives

    Castelletto, V., Ryumin, P., Cramer, R., Hamley, I., Taylor, M. N., Allsop, D., Reza, M., Ruokolainen, J., Arnold, T., Hermida-Merino, D., Garcia, C. I., Leal, M. C. & Castaño, E., 8/03/2017, In : Scientific Reports. 7, 12 p., 43637.

    Research output: Contribution to journalJournal article

  20. Published

    ß-Hairpin mimics containing a piperidine-pyrrolidine scaffold modulate the ß-amyloid aggregation process preserving the monomer species

    Pellegrino, S., Tonali, N., Erba, E., Kaffy, J., Taverna, M., Contini, A., Taylor, M. N., Allsop, D., Gelmi, M. L. & Ongeri, S., 1/02/2017, In : Chemical Science. 8, 2, p. 1295-1302 8 p.

    Research output: Contribution to journalJournal article

  21. Published

    Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer’s Aβ peptide

    Gregori, M., Taylor, M. N., Salvati, E., Re, F., Mancini, S., Balducci, C., Forloni, G., Zambelli, V., Sesana, S., Michael, M., Michail, C., Kolosov, O. V., Tinker-Mill, C. L., Sherer, M., Harris, S., Fullwood, N. J., Masserini, M. & Allsop, D., 02/2017, In : Nanomedicine: Nanotechnology, Biology, and Medicine. 13, 2, p. 723-732 10 p.

    Research output: Contribution to journalJournal article

  22. 2016
  23. Published

    Development and automation of a novel [18F]Fprosthetic group, 2-[18F]-fluoro-3-pyridinecarboxaldehyde, and its application to an amino(oxy)-functionalised Aβ peptide

    Morris, O., Gregory, J., Kadirvel, M., Henderson, F., Blykers, A., McMahon, A., Taylor, M. N., Allsop, D., Allan, S., Grigg, J., Boutin, H. & Prenant, C., 10/2016, In : Applied Radiation and Isotopes. 116, p. 120-127 8 p.

    Research output: Contribution to journalJournal article

  24. Published

    Magnetite pollution nanoparticles in the human brain

    Maher, B. A., Ahmed, I., Karloukovski, V. V., MacLaren, D., Foulds, P., Allsop, D., Mann, D., Torres-Jardon, R. & Calderon-Garciduenas, L., 27/09/2016, In : Proceedings of the National Academy of Sciences of the United States of America. 113, 39, p. 10797-10801 5 p.

    Research output: Contribution to journalJournal article

  25. Published

    Effects of different isoforms of apoE on aggregation of the α- synuclein protein implicated in Parkinson's disease

    Nouri Emamzadeh, F., Aojula, H., McHugh, P. & Allsop, D., 8/04/2016, In : Neuroscience Letters. 618, p. 146-151 6 p.

    Research output: Contribution to journalJournal article

  26. Published

    Designed glycopeptidomimetics disrupt protein−protein interactions mediating amyloid β‑peptide aggregation and restore neuroblastoma cell viability

    Kaffy, J., Brinet, D., Soulier, J-L., Tonali, N., Fera, K. F., Iacone, Y., Hoffmann, A. R. F., Khemtemourian, L., Crousse, B., Taylor, M. N., Allsop, D., Taverna, M., Lequin, O. & Ongeri, S., 10/03/2016, In : Journal of Medicinal Chemistry. 59, 5, p. 2025-2040 16 p.

    Research output: Contribution to journalJournal article

  27. 2015
  28. Published

    A preliminary electron microscopic investigation into the interaction between Aβ1-42 peptide and a novel nanoliposome- coupled retro-inverso peptide inhibitor, developed as a potential treatment for Alzheimer's disease

    Sherer, M., Fullwood, N. J., Taylor, M. & Allsop, D., 1/10/2015, In : Journal of Physics: Conference Series. 644, 1, 4 p., 012040.

    Research output: Contribution to journalJournal article

  29. 2014
  30. Published

    Nanomechanical and nanothermal mapping of initial stages of amyloid fibres formation

    Kolosov, O., Tovee, P., Tinker-Mill, C. & Allsop, D., 15/09/2014, p. 29. 1 p.

    Research output: Contribution to conference - Without ISBN/ISSN Abstract

  31. Published

    Amyloid β-peptide and Alzheimer's disease

    Allsop, D. & Mayes, J., 18/08/2014, In : Essays in Biochemistry. 56, p. 99-110 12 p., 7.

    Research output: Contribution to journalLiterature review

  32. Published

    Amyloid-β fibrils in Alzheimer's Disease are not inert when bound to copper ions but can degrade hydrogen peroxide and generate reactive oxygen species

    Mayes, J., Tinker-Mill, C., Kolosov, O., Zhang, H., Tabner, B. & Allsop, D., 25/04/2014, In : Journal of Biological Chemistry. 289, p. 12052-12062 11 p.

    Research output: Contribution to journalJournal article

  33. Published

    Ultrasonic force microscopy for nanomechanical characterization of early and late-stage amyloid-β peptide aggregation

    Tinker-Mill, C., Mayes, J., Allsop, D. & Kolosov, O., 2014, In : Scientific Reports. 4, 7 p., 4004.

    Research output: Contribution to journalJournal article

  34. 2013
  35. Published

    Correlation of Aβ oligomer levels in matched cerebrospinal fluid and serum samples

    Kasai, T., Tokuda, T., Taylor, M., Kondo, M., Mann, D. M. A., Foulds, P., Nakagawa, M. & Allsop, D., 13/09/2013, In : Neuroscience Letters. 551, p. 17-22 6 p.

    Research output: Contribution to journalJournal article

  36. Published

    A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson’s disease

    Foulds, P., Diggle, P., Mitchell, J. D., Parker, A., Hasegawa, M., Masuda-Suzukake, M., Mann, D. M. A. & Allsop, D., 29/08/2013, In : Scientific Reports. 3, 6 p., 2540.

    Research output: Contribution to journalJournal article

  37. Published

    A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease

    Foulds, PG., Diggle, P., Mitchell, JD., Parker, A., Hasegawa, M., Masuda-Suzukake, M., Mann, DM. & Allsop, D., 2013, In : Scientific Reports. 3, 6 p., 2540.

    Research output: Contribution to journalJournal article

  38. Published

    A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer's Disease

    Parthsarathy, V., McClean, P. L., Hölscher, C., Taylor, M., Tinker, C., Jones, G., Kolosov, O., Salvati, E., Gregori, M., Masserini, M. & Allsop, D., 2013, In : PLoS ONE. 8, 1, 11 p., e54769.

    Research output: Contribution to journalJournal article

  39. Published

    A possible key role for redox-active metal ions and soluble oligomers in neurodegenerative diseases

    Tabner, B., Moore, S., Mayes, J. & Allsop, D., 2013, Brain diseases and metalloproteins. Brown, D. R. (ed.). Boca Raton, Fla.: Pan Stanford, p. 11-32 22 p.

    Research output: Contribution in Book/Report/Proceedings - With ISBN/ISSNChapter

  40. 2012
  41. Published

    Utilization of a multiple antigenic peptide as a calibration standard in the BAN50 single antibody sandwich ELISA for Aß oligomers

    Kasai, T., Tokuda, T., Taylor, M., Nakagawa, M. & Allsop, D., 8/06/2012, In : Biochemical and Biophysical Research Communications. 422, 3, p. 375-380 6 p.

    Research output: Contribution to journalJournal article

  42. Published

    Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies

    Foulds, P., Yokota, O., Thurston, A., Davidson, Y., Ahmed, Z., Holton, J., Thompson, J. C., Akiyama, H., Arai, T., Hasegawa, M., Gerhard, A., Allsop, D. & Mann, D. M. A., 01/2012, In : Neurobiology of Disease. 45, 1, p. 188-195 8 p.

    Research output: Contribution to journalJournal article

  43. Published

    Nanoscale SPM characterisation of nacre aragonite plates and synthetic human amyloid fibres

    Grishin, I., Tinker, C., Allsop, D., Robson, A. & Kolosov, O., 2012, NSTI-Nanotech 2012. Santa Clara, USA: CRC PRESS-TAYLOR & FRANCIS GROUP, Vol. 1. p. 110-113 4 p.

    Research output: Contribution in Book/Report/Proceedings - With ISBN/ISSNConference contribution/Paper

  44. Published

    Phosphorylated α-synuclein as a potential biomarker for Parkinson's disease (Editorial)

    Foulds, P., Mann, D. & Allsop, D., 2012, In : Expert Review of Molecular Diagnostics. 12, 2, p. 115-117 3 p.

    Research output: Contribution to journalEditorial

  45. 2011
  46. Published

    TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's Syndrome: association with age, hippocampal sclerosis and clinical phenotype

    Davidson, Y. S., Raby, S., Foulds, P., Robinson, A., Thompson, J. C., Sikkink, S., Yusuf, I., Amin, H., Duplessis, D., Troakes, C., Al-Sarraj, S., Sloan, C., Esiri, M. M., Prasher, V. P., Allsop, D., Neary, D., Pickering-Brown, S. M., Snowden, J. S. & Mann, D. M. A., 12/2011, In : Acta Neuropathologica. 122, 6, p. 703-713 11 p.

    Research output: Contribution to journalJournal article

  47. Published

    Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide

    Taylor, M., Moore, S., Mourtas, S., Niarakis, A., Re, F., Zona, C., La Ferla, B., Nicotra, F., Masserini, M., Antimisiaris, S. G., Gregori, M. & Allsop, D., 10/2011, In : Nanomedicine: Nanotechnology, Biology, and Medicine. 7, 5, p. 541-550 10 p.

    Research output: Contribution to journalJournal article

  48. Published

    The amylin peptide implicated in type 2 diabetes stimulates copper-mediated carbonyl group and ascorbate radical formation

    Masad, A., Tabner, B. J., Mayes, J. & Allsop, D., 15/08/2011, In : Free Radical Biology and Medicine. 51, 4, p. 869-875 7 p.

    Research output: Contribution to journalJournal article

  49. Published

    Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease

    Foulds, P., Mitchell, J. D., Parker, A., Turner, R., Green, G., Diggle, P., Hasegawa, M., Taylor, M., Mann, D. & Allsop, D., 2011, In : The FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 25, 12, p. 4127-4137 11 p.

    Research output: Contribution to journalJournal article

  50. 2010
  51. Published

    Hypothesis: soluble Aβ oligomers in association with redox-active metal ions are the optimal generators of reactive oxygen species in Alzheimer's disease

    Tabner, B. J., Mayes, J. & Allsop, D., 8/10/2010, In : International Journal of Alzheimer's Disease. 2011, 6 p., 546380.

    Research output: Contribution to journalJournal article

  52. Published

    Parkinson disease: progress towards a molecular biomarker for Parkinson disease

    Foulds, P., Mann, D. M. A., Mitchell, J. D. & Allsop, D., 07/2010, In : Nature Reviews Neurology. 6, 7, p. 359-361 3 p.

    Research output: Contribution to journalJournal article

  53. Published

    Development of a proteolytically stable retro-inverso peptide inhibitor of β-amyloid oligomerization as a potential novel treatment for Alzheimer's disease

    Taylor, M., Moore, S., Mayes, J., Parkin, E., Beeg, M., Canovi, M., Gobbi, M., Mann, D. M. A. & Allsop, D., 2010, In : Biochemistry. 49, 15, p. 3261-3272 12 p.

    Research output: Contribution to journalJournal article

  54. Published

    High-molecular-weight β-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients

    Fukumoto, H., Tokuda, T., Kasai, T., Ishigami, N., Hidaka, H., Kondo, M., Allsop, D. & Nakagawa, M., 2010, In : The FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 24, 8, p. 2716-2726 11 p.

    Research output: Contribution to journalJournal article

  55. 2009
  56. Published

    Galantamine inhibits β-amyloid aggregation and cytotoxicity

    Matharu, B., Gibson, G., Parsons, R., Huckerby, T. N., Moore, S. A., Cooper, L. J., Millichamp, R., Allsop, D. & Austen, B., 15/05/2009, In : Journal of the Neurological Sciences. 280, 1-2, p. 49-58 10 p.

    Research output: Contribution to journalJournal article

  57. Published

    Detection of elevated levels of soluble α-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies

    Paleologou, K. E., Kragh, C. L., Mann, D. M. A., Salem, S. A., Al-Shami, R., Allsop, D., Hassan, A. H., Jensen, P. H. & El-Agnaf, O. M. A., 2009, In : Brain. 132, 4, p. 1093-1101 9 p.

    Research output: Contribution to journalJournal article

  58. Published

    Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis

    Kasai, T., Tokuda, T., Ishigami, N., Sasayama, H., Foulds, P., Mitchell, D. J., Mann, D. M. A., Allsop, D. & Nakagawa, M., 2009, In : Acta Neuropathologica. 117, 1, p. 55-62 8 p.

    Research output: Contribution to journalJournal article

  59. Published

    Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration

    Foulds, P., Davidson, Y., Mishra, M., Hobson, D. J., Humphreys, K. M., Taylor, M., Johnson, N., Weintraub, S., Akiyama, H., Arai, T., Hasegawa, M., Bigio, E. H., Benson, F. E., Allsop, D. & Mann, D. M. A., 2009, In : Acta Neuropathologica. 118, 5, p. 647-658 12 p.

    Research output: Contribution to journalJournal article

  60. 2008
  61. Published

    Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's β-amyloid peptide

    Austen, B. M., Paleologou, K. E., Ali, S. A. E., Qureshi, M. M., Allsop, D. & El-Agnaf, O. M. A., 2008, In : Biochemistry. 47, 7, p. 1984-1992 9 p.

    Research output: Contribution to journalJournal article

  62. Published

    Metal-dependent generation of reactive oxygen species from amyloid proteins implicated in neurodegenerative disease

    Allsop, D., Mayes, J., Moore, S., Masad, A. & Tabner, B. J., 2008, In : Biochemical Society Transactions. 36, 6, p. 1293-1298 6 p.

    Research output: Contribution to journalJournal article

  63. Published

    TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration

    Foulds, P., McAuley, E., Gibbons, L., Davidson, Y., Pickering-Brown, S. M., Neary, D., Snowden, J. S., Allsop, D. & Mann, D. M. A., 2008, In : Acta Neuropathologica. 116, 2, p. 141-146 6 p.

    Research output: Contribution to journalJournal article

Previous 1 2 3 Next

Back to top